Aurobindo Pharma reported INR49.54B in Gross Profit on Sales for its fiscal quarter ending in March of 2025.


Gross Profit On Sales Change Date
Cipla INR 45.34B 66.3M Jun/2025
Divis Laboratories Ltd 14.54B 1.5B Jun/2025
Dr.Reddys Laboratories INR 48.63B 8.16B Jun/2025
Hindustan Unilever INR 79.12B 890M Jun/2025
Sun Pharmaceuticals INR 109.71B 6.5B Jun/2025
UPL INR 50.47B 19.75B Jun/2025